WEKO3
アイテム
ニュージーランドマウス(NZB/WF_1)の腎障害に対するグリチルリチンの作用
https://kindai.repo.nii.ac.jp/records/2002473
https://kindai.repo.nii.ac.jp/records/2002473385138eb-c45b-4482-bd7d-0bc0baa8e3f9
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | ☆紀要論文 / Departmental Bulletin Paper(1) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2025-02-26 | |||||||||
タイトル | ||||||||||
タイトル | ニュージーランドマウス(NZB/WF_1)の腎障害に対するグリチルリチンの作用 | |||||||||
言語 | ja | |||||||||
タイトル | ||||||||||
タイトル | Effects of glycyrrhizin on renal failure in NZB/WF_1 mice | |||||||||
言語 | en | |||||||||
著者 |
織田, 真智子
× 織田, 真智子
|
|||||||||
言語 | ||||||||||
言語 | jpn | |||||||||
キーワード | ||||||||||
主題 | Glycyrrhizin, dexamethazone, NZB/WF_1 mice | |||||||||
資源タイプ | ||||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
資源タイプ | departmental bulletin paper | |||||||||
出版タイプ | ||||||||||
出版タイプ | AM | |||||||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||||||
出版者 名前 | ||||||||||
出版者 | 近畿大学医学会 | |||||||||
言語 | ja | |||||||||
bibliographic_information |
ja : 近畿大学医学雑誌 en : Medical Journal of Kinki University 巻 16, 号 4, p. 581-593, 発行日 1991-12-25 |
|||||||||
ISSN | ||||||||||
収録物識別子タイプ | PISSN | |||||||||
収録物識別子 | 03858367 | |||||||||
内容記述 | ||||||||||
内容記述タイプ | Abstract | |||||||||
内容記述 | The effects of glychrrhizin (Gly.) and dexamethazone (Dexa.) and the combination of the two drugs on the development of renal disease and survival in female NZB/WF_1 mice were examined. The mice were treated with Gly. (dose 20 mg/kg of body weight) or Dexa. (dose 1.0 mg/kg of body weight) or a combination of the two drugs twice a week. These treatments were started at 4 weeks old and 20 weeks old. Control mice were given saline. Body weight and proteinuria were measured every two weeks and renal histology, hemolytic test (against sheep red blood cells) and the number of plaque forming cells were observed at 8 months old. When these treatments were started at 4 weeks old, the survival time was 314 days in Gly. -treated mice, 351 days in Dexa. -treated mice, 378 days in mice treated with both drugs and 263 days in untreated control mice. Survival time was prolonged similarly in Gly. -treated mice and in mice treated with Gly. and Dexa. starting at 20 weeks old. Administrations of Gly., Dexa., or both drugs protected NZB/WF_1 mice from the development of glomerulonephritis and the combination therapy of the two drugs was the most effective. These results indicate that the use of Gly. alone or the combination of Gly. and a steroid might be valuable against autoimmune diseases. | |||||||||
言語 | en | |||||||||
内容記述 | ||||||||||
内容記述タイプ | Other | |||||||||
内容記述 | 本文データはCiNiiから複製したものである。 | |||||||||
言語 | ja |